| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rubius Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25,000 | 12 May 2022 | Direct | ||
| Kaleido Biosciences, Inc. | Director | Stock Option (Right to Buy) | 15,000 | 30 Jun 2021 | Direct | ||
| Galecto, Inc. | Director | Stock Option (right to buy) | 720 | 18 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLTO | Galecto, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 07:00 |
| GLTO | Galecto, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:00 |
| GLTO | Galecto, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:00 |
| GLTO | Galecto, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 15 Jun 2022, 16:00 |
| /report/000117911022003012-prener-anne-2022-05-12 | Rubius Therapeutics, Inc. | 12 May 2022 | 1 | $0 | 4 | Director | 13 May 2022, 16:35 |
| /report/000120919121044407-prener-anne-2021-06-30 | Kaleido Biosciences, Inc. | 30 Jun 2021 | 1 | $0 | 4 | Director | 01 Jul 2021, 16:28 |
| GLTO | Galecto, Inc. | 26 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 16:00 |
| /report/000117911021005311-prener-anne-2021-05-12 | Rubius Therapeutics, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 13 May 2021, 20:34 |